Complement Receptor Deficiency Treatment & Management

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Dirk M Elston, MD   more...
 
Updated: May 27, 2011
 

Medical Care

No specific treatment is required for complement receptor deficiencies, other than symptomatic treatment for associated autoimmune disorders or recurrent infections.

Bone marrow transplantation may be of help in severe cases of leukocyte adhesion deficiency syndrome. Hematopoietic stem-cell transplantation is of long-term benefit and an early therapeutic option with a suitable HLA-matched stem cell.[11]

Next

Consultations

In patients with severe SLE or other autoimmune disorders, referral to a rheumatologist or an internist may be advised.

In patients with leukocyte adhesion deficiency syndrome, a pediatrician and an infectious diseases specialist is needed in the neonatal period.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Isabelle Thomas, MD  Associate Professor, Department of Dermatology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School; Chief of Dermatology Service, Veterans Affairs Medical Center of East Orange

Isabelle Thomas, MD is a member of the following medical societies: American Academy of Dermatology and Sigma Xi

Disclosure: Nothing to disclose.

Specialty Editor Board

Evan R Farmer, MD  Clinical Professor of Pathology and Dermatology, Department of Pathology, Virginia Commonwealth University School of Medicine

Evan R Farmer, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society of Dermatopathology, and International Society of Dermatology

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey P Callen, MD  Professor of Medicine (Dermatology), Chief, Division of Dermatology, University of Louisville School of Medicine

Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology

Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Consulting fee Consulting; Celgene Honoraria Safety Monitoring Committee; GSK - Glaxo Smith Kline Consulting fee Consulting; TenXBioPharma Consulting fee Safety Monitoring Committee

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Department of Dermatology, Geisinger Medical Center

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References

  1. Weaver DJ Jr, Reis ES, Pandey MK, Köhl G, Harris N, Gerard C, et al. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol. Mar 2010;40(3):710-21. [Medline].

  2. Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, et al. Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart. J Immunol. Mar 15 2006;176(6):3516-24. [Medline].

  3. Jacobson AC, Weis JJ, Weis JH. Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner. J Immunol. Apr 1 2008;180(7):5057-66. [Medline].

  4. Boos L, Campbell IL, Ames R, Wetsel RA, Barnum SR. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J Immunol. Oct 1 2004;173(7):4708-14. [Medline].

  5. Tone Y, Wada T, Shibata F, Toma T, Hashida Y, Kasahara Y, et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood. Feb 1 2007;109(3):1182-4. [Medline].

  6. Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. Mar 2009;15(3):306-12. [Medline].

  7. Yashoda-Devi BK, Rakesh N, Devaraju D, Santana N. Leukocyte adhesion deficiency type I--a focus on oral disease in a young child. Med Oral Patol Oral Cir Bucal. Mar 1 2011;16(2):e153-7. [Medline].

  8. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med. Jul 1 1980;152(1):20-30. [Medline].

  9. Nord KM, Pappert AS, Grossman ME. Pyoderma Gangrenosum-like Lesions in Leukocyte Adhesion Deficiency I Treated with Intravenous Immunoglobulin. Pediatr Dermatol. Mar 2011;28(2):156-61. [Medline].

  10. Bautsch W, Hoymann HG, Zhang Q, Meier-Wiedenbach I, Raschke U, Ames RS, et al. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol. Nov 15 2000;165(10):5401-5. [Medline].

  11. Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics. Mar 2009;123(3):836-40. [Medline].

  12. Anderson DC, Schmalstieg FC, Arnaout MA, Kohl S, Tosi MF, Dana N, et al. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest. Aug 1984;74(2):536-51. [Medline].

  13. Atkinson JP. Complement deficiency. Predisposing factor to autoimmune syndromes. Am J Med. Dec 23 1988;85(6A):45-7. [Medline].

  14. Barrington RA, Zhang M, Zhong X, Jonsson H, Holodick N, Cherukuri A, et al. CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses. J Immunol. Sep 1 2005;175(5):2859-67. [Medline].

  15. Bartholomew WR, Shanahan TC. Complement components and receptors: deficiencies and disease associations. Immunol Ser. 1990;52:33-51. [Medline].

  16. Bowen TJ, Ochs HD, Altman LC, Price TH, Van Epps DE, Brautigan DL, et al. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr. Dec 1982;101(6):932-40. [Medline].

  17. Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol. 2000;74:61-88. [Medline].

  18. Colten HR, Rosen FS. Complement deficiencies. Annu Rev Immunol. 1992;10:809-34. [Medline].

  19. Davies KA. Complement. Baillieres Clin Haematol. Dec 1991;4(4):927-55. [Medline].

  20. Fischer A, Seger R, Durandy A, Grospierre B, Virelizier JL, Le Deist F, et al. Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest. Dec 1985;76(6):2385-92. [Medline].

  21. Glovsky MM, Ward PA, Johnson KJ. Complement determinations in human disease. Ann Allergy Asthma Immunol. Dec 2004;93(6):513-22; quiz 523-5, 605. [Medline].

  22. Haas KM, Tedder TF. Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity. Adv Exp Med Biol. 2005;560:125-39. [Medline].

  23. Harlan JM. Leukocyte adhesion deficiency syndrome: insights into the molecular basis of leukocyte emigration. Clin Immunol Immunopathol. Jun 1993;67(3 Pt 2):S16-24. [Medline].

  24. Holers VM. Phenotypes of complement knockouts. Immunopharmacology. Aug 2000;49(1-2):125-31. [Medline].

  25. Kazatchkine MD, Fearon DT. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodefic Rev. 1990;2(1):17-41. [Medline].

  26. Kazatchkine MD, Jouvin MH, Wilson JG, Fischer E, Fischer A. Human diseases associated with C3 receptor deficiencies. Immunol Lett. Feb 1987;14(3):191-5. [Medline].

  27. Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol. Nov 15 2000;165(10):5406-9. [Medline].

  28. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology. Dec 1997;38(1-2):51-62. [Medline].

  29. Köhl J, Gessner JE. On the role of complement and Fc gamma-receptors in the Arthus reaction. Mol Immunol. Sep-Oct 1999;36(13-14):893-903. [Medline].

  30. Morgan BP, Daha M, Meri S, Nicholson-Weller A. Into the third century of complement research. Immunol Today. Dec 2000;21(12):603-5. [Medline].

  31. Moulds JM, Krych M, Holers VM, Liszewski MK, Atkinson JP. Genetics of the complement system and rheumatic diseases. Rheum Dis Clin North Am. Nov 1992;18(4):893-914. [Medline].

  32. Nielsen CH, Fischer EM, Leslie RG. The role of complement in the acquired immune response. Immunology. May 2000;100(1):4-12. [Medline].

  33. Nybo M, Sørensen O, Leslie R, Wang P. Reduced expression of C5a receptors on neutrophils from cord blood. Arch Dis Child Fetal Neonatal Ed. Mar 1998;78(2):F129-32. [Medline].

  34. Perlmutter DH, Colten HR. Molecular basis of complement deficiencies. Immunodefic Rev. 1989;1(2):105-33. [Medline].

  35. Reid RR, Woodcock S, Prodeus AP, Austen J, Kobzik L, Hechtman H, et al. The role of complement receptors CD21/CD35 in positive selection of B-1 cells. Curr Top Microbiol Immunol. 2000;252:57-65. [Medline].

  36. Rhein LM, Perkins M, Gerard NP, Gerard C. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia. Am J Respir Cell Mol Biol. Apr 2008;38(4):401-6. [Medline].

  37. Rigal D, Andreoni C, Vermot-Desroches C, Rousset F, Souillet G, Robert J. [Physiopathological roles of leukocyte adhesion proteins: LFA-1, CR3, P150-95 in man]. Pediatrie. 1988;43(3):185-90. [Medline].

  38. Smiley JD, Moore SE Jr. Immune-complex vasculitis: role of complement and IgG-Fc receptor functions. Am J Med Sci. Oct 1989;298(4):267-77. [Medline].

  39. Tedder TF, Poe JC, Fujimoto M, Haas KM, Sato S. The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun. 2005;8:55-90. [Medline].

  40. Webb J, Whaley K. Complement and immune complex diseases. Aust N Z J Med. Apr 1986;16(2):268-78. [Medline].

  41. Whaley K, Schwaeble W. Complement and complement deficiencies. Semin Liver Dis. 1997;17(4):297-310. [Medline].

  42. Wilson JG, Ratnoff WD, Schur PH, Fearon DT. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. Arthritis Rheum. Jun 1986;29(6):739-47. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.